BNXTF
Price
$0.61
Change
-$0.02 (-3.17%)
Updated
Sep 26 closing price
Capitalization
72.33M
DRRX
Price
$1.91
Change
-$0.02 (-1.04%)
Updated
Sep 10 closing price
Capitalization
59.31M
Interact to see
Advertisement

BNXTF vs DRRX

Header iconBNXTF vs DRRX Comparison
Open Charts BNXTF vs DRRXBanner chart's image
BIONXT SOLUTIONS
Price$0.61
Change-$0.02 (-3.17%)
Volume$15.95K
Capitalization72.33M
DURECT
Price$1.91
Change-$0.02 (-1.04%)
Volume$2.79M
Capitalization59.31M
BNXTF vs DRRX Comparison Chart in %
Loading...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. DRRX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and DRRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BNXTF: $0.61 vs. DRRX: $1.91)
Brand notoriety: BNXTF and DRRX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 298% vs. DRRX: 125%
Market capitalization -- BNXTF: $72.33M vs. DRRX: $59.31M
BNXTF [@Pharmaceuticals: Generic] is valued at $72.33M. DRRX’s [@Pharmaceuticals: Generic] market capitalization is $59.31M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileDRRX’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • DRRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BNXTF and DRRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 3 TA indicator(s) are bullish while DRRX’s TA Score has 3 bullish TA indicator(s).

  • BNXTF’s TA Score: 3 bullish, 6 bearish.
  • DRRX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, DRRX is a better buy in the short-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а +4.24% price change this week, while DRRX (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNXTF($72.3M) has a higher market cap than DRRX($59.3M). DRRX YTD gains are higher at: 154.667 vs. BNXTF (140.834). BNXTF has higher annual earnings (EBITDA): -4.93M vs. DRRX (-15.23M). DRRX has more cash in the bank: 6.5M vs. BNXTF (4.24K). DRRX has less debt than BNXTF: DRRX (1.75M) vs BNXTF (7.06M). DRRX has higher revenues than BNXTF: DRRX (1.66M) vs BNXTF (21.7K).
BNXTFDRRXBNXTF / DRRX
Capitalization72.3M59.3M122%
EBITDA-4.93M-15.23M32%
Gain YTD140.834154.66791%
P/E RatioN/AN/A-
Revenue21.7K1.66M1%
Total Cash4.24K6.5M0%
Total Debt7.06M1.75M404%
FUNDAMENTALS RATINGS
DRRX: Fundamental Ratings
DRRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNXTFDRRX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.421.15
+4.55%
GameStop Corp
TSLA440.4017.01
+4.02%
Tesla
SPY661.823.77
+0.57%
SPDR® S&P 500® ETF
AAPL255.46-1.41
-0.55%
Apple

BNXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNXTF has been loosely correlated with DRRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BNXTF jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
-4.37%
DRRX - BNXTF
62%
Loosely correlated
N/A
HLBBF - BNXTF
27%
Poorly correlated
N/A
PAHC - BNXTF
26%
Poorly correlated
+2.02%
SDZXF - BNXTF
24%
Poorly correlated
N/A
AMPH - BNXTF
24%
Poorly correlated
+1.86%
More

DRRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRRX has been loosely correlated with BNXTF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if DRRX jumps, then BNXTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
N/A
BNXTF - DRRX
62%
Loosely correlated
-4.37%
HLBBF - DRRX
38%
Loosely correlated
N/A
ANIP - DRRX
38%
Loosely correlated
-0.34%
SUPN - DRRX
32%
Poorly correlated
-0.32%
PAHC - DRRX
30%
Poorly correlated
+2.02%
More